Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Motzer

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Urology|July 4, 2001
A postoperative prognostic nomogram for renal cell carcinomaM W Kattan, V Reuter, R J Motzer, et al.
Cancer Research|September 15, 1988
Blood group-related antigens in human germ cell tumorsR J Motzer, V E Reuter, C Cordon-Cardo, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
The evolving role of chemotherapy of germ cell tumorsH I Scher, D F Bajorin, R J Motzer, et al.
Seminars in Oncology|December 1, 1992
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experienceR J Motzer, D F Bajorin, V Vlamis, et al.
Cancer Genetics and Cytogenetics|December 1, 1992
t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcomaE Rodriguez, C Sreekantaiah, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Survival and prognostic stratification of 670 patients with advanced renal cell carcinomaR J Motzer, M Mazumdar, J Bacik, et al.
Journal of the National Cancer Institute|January 6, 1993
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapyD F Bajorin, R J Motzer, E Rodriguez, et al.
Seminars in Oncology|June 1, 1993
Genetic analysis in the diagnosis of neoplasms of unknown primary tumor siteD H Ilson, R J Motzer, E Rodriguez, et al.
Investigational New Drugs|January 1, 1995
Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumorsH S Puc, D F Bajorin, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, D F Bajorin, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Urology|July 4, 2001
A postoperative prognostic nomogram for renal cell carcinomaM W Kattan, V Reuter, R J Motzer, et al.
Cancer Research|September 15, 1988
Blood group-related antigens in human germ cell tumorsR J Motzer, V E Reuter, C Cordon-Cardo, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
The evolving role of chemotherapy of germ cell tumorsH I Scher, D F Bajorin, R J Motzer, et al.
Seminars in Oncology|December 1, 1992
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experienceR J Motzer, D F Bajorin, V Vlamis, et al.
Cancer Genetics and Cytogenetics|December 1, 1992
t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcomaE Rodriguez, C Sreekantaiah, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Survival and prognostic stratification of 670 patients with advanced renal cell carcinomaR J Motzer, M Mazumdar, J Bacik, et al.
Journal of the National Cancer Institute|January 6, 1993
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapyD F Bajorin, R J Motzer, E Rodriguez, et al.
Seminars in Oncology|June 1, 1993
Genetic analysis in the diagnosis of neoplasms of unknown primary tumor siteD H Ilson, R J Motzer, E Rodriguez, et al.
Investigational New Drugs|January 1, 1995
Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumorsH S Puc, D F Bajorin, G J Bosl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, D F Bajorin, et al.
Pageof 16